Affiliation:
1. Xiamen University
2. the First Affiliated Hospital of Xiamen University, Xiamen University
Abstract
Abstract
Objective: The prevalence of Sarcopenic obesity (SO) is increasing, particularly with a rising trend observed in patients diagnosed with Type 2 diabetes (T2D). However, the association between SO and diabetic complications remains unclear when compared to sarcopenia or obesity alone. This study aimed to investigate the associations between sarcopenia, obesity, SO, and diabetes complications in patients with T2D.
Methods: A retrospective study was conducted including 2387 hospitalized patients with T2D. Data associated with demographic characteristics, biochemical parameters, diabetic complications, and body composition from electronic health records were collected. The participants were categorized as normal (nonsarcopenia nonobesity), sarcopenia, obesity, and SO groups according to the body compositions evaluated by dual-energy X-ray absorptiometry. Multiple logistic regression models were applied to assess the associations between body composition and complications of diabetes.
Results: After adjustment for potential confounders, compared with patients in normal group, the odds ratios (95% CIs) of macrovascular complications of diabetes were 0.64 (95% CI, 0.29-1.42) for those in sarcopenia group, 1.05 (95% CI, 0.56-1.97) in obesity group, and 2.45 (95% CI, 1.18-5.09) in SO group, respectively; the odds ratios (95% CIs) of microvascular complications of diabetes was 0.95 (95% CI, 0.58-1.55) for those in sarcopenia group, 0.80 (95% CI, 0.53-1.22) in obesity group, and 1.21 (95% CI, 0.69-2.11) in SO group, respectively.
Conclusion: According to our findings, SO, rather than sarcopenia or obesity alone, was significantly associated with a higher prevalence of macrovascular complications, in hospitalized patients with T2DM. This association was not observed for diabetic microvascular complications.
Publisher
Research Square Platform LLC
Reference24 articles.
1. The Impact of Glucose-Lowering Drugs on Sarcopenia in Type 2 Diabetes: Current Evidence and Underlying Mechanisms;Massimino E;Cells,2021
2. Metabolic profile and quality of life in class I sarcopenic overweight and obese postmenopausal women: a MONET study. Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme;Messier V,2009
3. Sarcopenia and sarcopenic obesity classifications and cardiometabolic risks in older women;Santos EP;Arch Gerontol Geriatr,2014
4. Sarcopenic Obesity: Epidemiologic Evidence, Pathophysiology, and Therapeutic Perspectives;Koliaki C;Curr Obes Rep,2019
5. Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists;Garvey WT,2016